相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions
F. Van den Bosch et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry
Bente Glintborg et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry
Merete Lund Hetland et al.
ARTHRITIS AND RHEUMATISM (2010)
Biological Therapy for Psoriatic Arthritis in Clinical Practice: Outcomes Up to 2 Years
Liisa M. Virkki et al.
JOURNAL OF RHEUMATOLOGY (2010)
An open-source, self-explanatory touch screen in routine care. Validity of filling in the Bath measures on Ankylosing Spondylitis Disease Activity Index, Function Index, the Health Assessment Questionnaire and Visual Analogue Scales in comparison with paper versions
David B. Schefte et al.
RHEUMATOLOGY (2010)
Frequency, Predictors, and Prognosis of Sustained Minimal Disease Activity in an Observational Psoriatic Arthritis Cohort
Laura C. Coates et al.
ARTHRITIS CARE & RESEARCH (2010)
Remission in psoriatic arthritis: is it possible and how can it be predicted?
Tajvur P. Saber et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT
Dafna D. Gladman et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Treatment recommendations for psoriatic arthritis
C. T. Ritchlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Psoriatic arthritis assessment and treatment update
Philip J. Mease
CURRENT OPINION IN RHEUMATOLOGY (2009)
New biologics for psoriasis and psoriatic arthritis
Mariya Rozenblit et al.
DERMATOLOGIC THERAPY (2009)
Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis
Martin Rudwaleit et al.
JOURNAL OF RHEUMATOLOGY (2009)
The Challenge and Need of Defining Axial Psoriatic Arthritis
Jose Luis Fernandez-Sueiro
JOURNAL OF RHEUMATOLOGY (2009)
Capturing real-life patient care in psoriatic arthritis and its risks: the challenge of analysing registry data
Daniel Aletaha
ARTHRITIS RESEARCH & THERAPY (2009)
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
Amr A. Saad et al.
ARTHRITIS RESEARCH & THERAPY (2009)
The occurrence of psoriatic arthritis in Denmark
O. B. V. Pedersen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry
M. L. Hetland et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The comparative one-year performance of anti-tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis:: Results from a longitudinal, observational, multicenter study
Marte Schrumpf Heiberg et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients:: results from the South Swedish Arthritis Treatment Group register
L. E. Kristensen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study
M. S. Heiberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate
J. Gratacos et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial
A. Kavanaugh et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER Group
Loreto Carmona et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis - Results of a double-blind, randomized, placebo-controlled trial
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2005)
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
CE Antoni et al.
ARTHRITIS AND RHEUMATISM (2005)
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
DD Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Routine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)
ML Hetland et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
Etanercept treatment of psoriatic arthritis - Safety, efficacy, and effect on disease progression
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2004)
Systematic reviews in health care -: Assessing the quality of controlled clinical trials
P Jüni et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
分享论文
